| Views | |
|---|---|
| Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia | 14 |
| May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | October 2025 | November 2025 | |
|---|---|---|---|---|---|---|---|
| Tisagenlecleucel vs. historical standard of care in children and young adult patients with relapsed/refractory B-cell precursor acute lymphoblastic leukemia | 0 | 0 | 0 | 0 | 0 | 0 | 14 |
| Views | |
|---|---|
| 2023_v.Stackelberg_etal.pdf | 5 |
